FAST-ACTING INSULIN ASPART COMPARED WITH RAPID-ACTING INSULIN ANALOGS IN THE ADVANCED HYBRID CLOSED-LOOP SYSTEM IN ADULTS WITH TYPE 1 DIABETES

被引：0
|
作者：
Amuedo, S. [1 ]
Herguido, N. Gros [1 ]
Bellido, V. [1 ]
Gallardo, G. Lopez [1 ]
Vinau, F. Losada [1 ]
Morales, A. Perez [1 ]
Moreno, A. Soto [1 ]
机构：
[1] Virgen Rocio Univ Hosp, Endocrinol & Nutr Dept, Seville, Spain
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
898
引用
收藏
页码：A104 / A105
页数：2
相关论文
共 50 条
  • [1] Investigating the safety and glycaemic control of fast-acting insulin aspart with a closed-loop delivery system in adults with type 1 diabetes
    Russell, S. J.
    Balliro, C. A.
    Ekelund, M.
    El-Khatib, F.
    Graungaard, T.
    Jafri, R.
    Rathor, N.
    Sherwood, J.
    Damiano, E. R.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S346 - S346
  • [2] INVESTIGATING THE SAFETY AND GLYCAEMIC CONTROL OF FAST-ACTING INSULIN ASPART WITH A CLOSED-LOOP DELIVERY SYSTEM IN ADULTS WITH TYPE 1 DIABETES
    Russell, S.
    Balliro, C.
    Ekelund, M.
    El-Khatib, F.
    Graungaard, T.
    Jafri, R.
    Rathor, N.
    Sherwood, J.
    Damiano, E.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A37 - A37
  • [3] Cost impact analysis of mealtime fast-acting insulin aspart compared with insulin aspart in adults with Type 1 diabetes in the UK
    Pollock, R. F.
    Parekh, W.
    Watcham, S.
    Hallen, N.
    DIABETIC MEDICINE, 2019, 36 : 166 - 166
  • [4] Fast-Acting Insulin Aspart Versus Insulin Aspart Using a Second-Generation Hybrid Closed-Loop System in Adults With Type 1 Diabetes: A Randomized, Open-Label, Crossover Trial
    Lee, Melissa H.
    Paldus, Barbora
    Vogrin, Sara
    Morrison, Dale
    Zaharieva, Dessi P.
    Lu, Jean
    Jones, Hannah M.
    Netzer, Emma
    Robinson, Lesley
    Grosman, Benyamin
    Roy, Anirban
    Kurtz, Natalie
    Ward, Glenn M.
    MacIsaac, Richard J.
    Jenkins, Alicia J.
    O'Neal, David N.
    DIABETES CARE, 2021, 44 (10) : 2371 - 2378
  • [5] Efficacy and safety of fast-acting insulin aspart compared with insulin aspart, both with insulin degludec with or without metformin, in adults with type 2 diabetes
    Lane, W.
    Bozkurt, K.
    Favaro, E.
    Jang, H. C.
    Kjaersgaard, M. I. S.
    Oviedo, A.
    Rose, L.
    Senior, P.
    Sesti, G.
    Soto Gonzalez, A.
    Franek, E.
    DIABETOLOGIA, 2019, 62 : S10 - S11
  • [6] Fast Acting Insulin Aspart Compared with Insulin Aspart in the Medtronic 670G Hybrid Closed Loop System in Type 1 Diabetes: An Open Label Crossover Study
    Ozer, Kerem
    Cooper, Alison M.
    Ahn, Lily P.
    Waggonner, Cassidy R.
    Blevins, Thomas C.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (04) : 286 - 292
  • [7] Comparable Glucose Control with Fast-Acting Insulin Aspart Versus Insulin Aspart Using a Second-Generation Hybrid Closed-Loop System During Exercise
    Morrison, Dale
    Zaharieva, Dessi P.
    Lee, Melissa H.
    Paldus, Barbora
    Vogrin, Sara
    Grosman, Benyamin
    Roy, Anirban
    Kurtz, Natalie
    O'Neal, David Norman
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 (02) : 93 - 101
  • [8] Performance of Fast-Acting Aspart Insulin as Compared to Aspart Insulin in Insulin Pump for Managing Type 1 Diabetes Mellitus: A Meta-Analysis
    Dutta, Deep
    Mohindra, Ritin
    Mahajan, Kunal
    Sharma, Meha
    DIABETES & METABOLISM JOURNAL, 2023, 47 (01) : 72 - 81
  • [9] Efficacy and safety of fast-acting insulin aspart in adults with type 2 diabetes with different insulin requirements
    Sesti, G.
    Lane, W.
    Ekelund, M.
    Thorisdottir, O.
    Jodar, E.
    Oviedo, A.
    Rathor, N.
    Senior, P.
    Franek, E.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S330 - S330
  • [10] Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes
    Raskin, P
    Riis, A
    Guthrie, RA
    Jovanovic, L
    Leiter, L
    DIABETES CARE, 2000, 23 (05) : 583 - 588
12345